预防外周静脉导管相关感染及其他并发症措施的有效性与安全性:系统综述与Meta分析
该系统综述评估24项感染预防与控制干预措施预防外周静脉导管相关感染及其他并发症的效果,检索1980年1月1日至2023年3月16日对照研究,105项研究符合标准,覆盖16个研究问题,8个问题无研究。戴手套较不戴手套降低置入相关不良事件风险(校正RR 0.52,95%CI 0.33-0.85),按计划拔管较临床指征拔管可能降低成人血栓性静脉炎发生率(RR 0.74,95%可信区间0.49-1.01),新生儿氯己定消毒较非氯己定降低静脉炎评分(0.14 vs 0.68,P=0.003),其他措施无统计学显著差异。
要点
- 戴手套较不戴手套降低置入相关总体不良事件风险(校正RR 0.52,95%CI 0.33-0.85)。
- 成人按计划拔管较临床指征拔管可能降低血栓性静脉炎发生率(RR 0.74,95%可信区间0.49-1.01)。
- 新生儿氯己定消毒较非氯己定降低静脉炎评分(0.14 vs 0.68,P=0.003)。
核心结论
- 尽管外周静脉导管频繁使用且相关并发症受关注,本综述强调亟需更多高质量研究探讨安全外周静脉导管管理的有效感染预防与控制方法。
- 在缺乏有效证据的情况下,遵守标准预防措施和记录仍是遏制外周静脉导管并发症的最重要原则。
研究设计与样本
- 系统综述与Meta分析,检索Ovid MEDLINE、Embase、Cochrane Library、WHO Global Index Medicus、CINAHL及参考文献列表,纳入1980年1月1日至2023年3月16日的对照研究。
- 双人筛选研究、评估偏倚风险、提取数据并评定证据确定性;对3项及以上试验的结局进行贝叶斯随机效应Meta分析。
- 105项研究符合预设纳入标准,涉及24个研究问题中的16个;8个研究问题未发现研究。
主要发现
- 基于低至高质量证据,戴手套较不戴手套降低置入相关总体不良事件风险(1项非随机对照试验;校正RR 0.52,95%CI 0.33-0.85)。
- 成人按计划拔管较临床指征拔管可能降低血栓性静脉炎发生率(10项随机对照试验;RR 0.74,95%可信区间0.49-1.01)。
- 新生儿氯己定消毒较非氯己定消毒降低静脉炎评分(1项随机对照试验;0.14 vs 0.68,P=0.003)。
- 其他措施未发现统计学显著差异。
临床怎么用
- 原文结论指出,在缺乏有效证据的情况下,遵守标准预防措施和记录仍是遏制外周静脉导管并发症的最重要原则。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral intravenous catheters (PIVCs) contribute substantially to the global burden of infections. This systematic review assessed 24 infection prevention and control (IPC) interventions to prevent PIVC-associated infections and other complications. METHODS: We searched Ovid MEDLINE, Embase, Cochrane Library, WHO Global Index Medicus, CINAHL, and reference lists for controlled studies from 1 January 1980-16 March 2023. We dually selected studies, assessed risk of bias, extracted data, and rated the certainty of evidence (COE). For outcomes with 3 or more trials, we conducted Bayesian random-effects meta-analyses. RESULTS: 105 studies met our prespecified eligibility criteria, addressing 16 of the 24 research questions; no studies were identified for 8 research questions. Based on findings of low to high COE, wearing gloves reduced the risk of overall adverse events related to insertion compared with no gloves (1 non-randomized controlled trial [non-RCT]; adjusted risk ratio [RR], .52; 95% CI, .33-.85), and catheter removal based on defined schedules potentially resulted in a lower phlebitis/thrombophlebitis incidence (10 RCTs; RR, 0.74, 95% credible interval, .49-1.01) compared with clinically indicated removal in adults. In neonates, chlorhexidine reduced the phlebitis score compared with non-chlorhexidine-containing disinfection (1 RCT; 0.14 vs 0.68; P = .003). No statistically significant differences were found for other measures. CONCLUSIONS: Despite their frequent use and concern about PIVC-associated complications, this review underscores the urgent need for more high-quality studies on effective IPC methods regarding safe PIVC management. In the absence of valid evidence, adherence to standard precaution measures and documentation remain the most important principles to curb PIVC complications. CLINICAL TRIALS REGISTRATION: The protocol was registered in the Open Science Framework (https://osf.io/exdb4).
引用
- Dobrescu A, Constantin AM, Pinte L, et al. Effectiveness and Safety of Measures to Prevent Infections and Other Complications Associated With Peripheral Intravenous Catheters: A Systematic Review and Meta-analysis. Clin Infect Dis. 2024. PMID: 38593192. doi:10.1093/cid/ciae195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。